Synapto-protective drugs evaluation in reconstructed neuronal network by Deleglise, Bérangère et al.
Synapto-protective drugs evaluation in reconstructed
neuronal network
Be´range`re Deleglise, Benjamin Lassus, Vanessa Soubeyre, Aure´lie
Alleaume-Butaux, Johannes J. Hjorth, Maeva Vignes, Benoit Schneider,
Bernard Brugg, Jean-Louis Viovy, Jean-Michel Peyrin
To cite this version:
Be´range`re Deleglise, Benjamin Lassus, Vanessa Soubeyre, Aure´lie Alleaume-Butaux, Johannes
J. Hjorth, et al.. Synapto-protective drugs evaluation in reconstructed neuronal network. PLoS
ONE, Public Library of Science, 2013, 8 (8), pp.1-9. <10.1371/journal.pone.0071103>. <hal-
01221378>
HAL Id: hal-01221378
https://hal.archives-ouvertes.fr/hal-01221378
Submitted on 27 Oct 2015
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destine´e au de´poˆt et a` la diffusion de documents
scientifiques de niveau recherche, publie´s ou non,
e´manant des e´tablissements d’enseignement et de
recherche franc¸ais ou e´trangers, des laboratoires
publics ou prive´s.

Synapto-Protective Drugs Evaluation in Reconstructed
Neuronal Network
Be´range`re Deleglise1,2, Benjamin Lassus1,2, Vaneyssa Soubeyre1,2, Aure´lie Alleaume-Butaux3,4,
Johannes J. Hjorth6¤, Mae´va Vignes1,5, Benoit Schneider3,4, Bernard Brugg1,2, Jean-Louis Viovy5, Jean-
Michel Peyrin1,2*
1Neurobiologie des Processus Adaptatifs, CNRS, UMR7102, Paris, France, 2Universite´ Pierre et Marie Curie, Paris, France, 3 Inserm UMR-S 747, Paris, France, 4Universite´
Paris Descartes, Sorbonne Paris Cite´, UMR-S 747, Paris, France, 5Macromole´cules et Microsyste`mes, CNRS UMR168, Institut Curie, Paris, France, 6 Integrative
Neurophysiology, Center for Neurogenomics and Cognitive Research (CNCR), VU University Amsterdam, Amsterdam, The Netherlands
Abstract
Chronic neurodegenerative syndromes such as Alzheimer’s and Parkinson’s diseases, or acute syndromes such as ischemic
stroke or traumatic brain injuries are characterized by early synaptic collapse which precedes axonal and neuronal cell body
degeneration and promotes early cognitive impairment in patients. Until now, neuroprotective strategies have failed to
impede the progression of neurodegenerative syndromes. Drugs preventing the loss of cell body do not prevent the
cognitive decline, probably because they lack synapto-protective effects. The absence of physiologically realistic neuronal
network models which can be easily handled has hindered the development of synapto-protective drugs suitable for
therapies. Here we describe a new microfluidic platform which makes it possible to study the consequences of axonal
trauma of reconstructed oriented mouse neuronal networks. Each neuronal population and sub-compartment can be
chemically addressed individually. The somatic, mid axon, presynaptic and postsynaptic effects of local pathological stresses
or putative protective molecules can thus be evaluated with the help of this versatile ‘‘brain on chip’’ platform. We show
that presynaptic loss is the earliest event observed following axotomy of cortical fibers, before any sign of axonal
fragmentation or post-synaptic spine alteration. This platform can be used to screen and evaluate the synapto-protective
potential of several drugs. For instance, NAD+ and the Rho-kinase inhibitor Y27632 can efficiently prevent synaptic
disconnection, whereas the broad-spectrum caspase inhibitor zVAD-fmk and the stilbenoid resveratrol do not prevent
presynaptic degeneration. Hence, this platform is a promising tool for fundamental research in the field of developmental
and neurodegenerative neurosciences, and also offers the opportunity to set up pharmacological screening of axon-
protective and synapto-protective drugs.
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Introduction
In chronic neurodegenerative syndromes such as Alzheimer’s
and Parkinson’s diseases, or acute syndromes such as ischemic
stroke or traumatic brain injuries, neuronal degeneration proceeds
through a protracted dying-back pattern in which dysfunction of
nerve terminals precedes neuronal cell body destruction [1,2,3].
Progressive loss of synaptic connections leads to the lack of
controlled synaptic transmission, generation of abnormal neuro-
transmission, and a reduced level of trophic factors, resulting in
impairment of postsynaptic neuronal survival and therefore
progressive weakening of the robustness of interconnected
networks. These events may account for early cognitive symptoms
in patients [4,5]. Synapse failure thus plays a critical role in the
initiation and progression of many neurodegenerative conditions
[6,7,8,9]. Moreover, as evidenced by Braak and co-workers,
degeneration associated with Alzheimer’s or Parkinson’s diseases
follows specific neuronal pathways in the brain [6,7,8,9,10,11,12].
Together, these observations highlight the need to study neuro-
degenerative processes at the neuronal network level [13,14,15].
Synaptic degeneration being an early and seminal process in
various acute and chronic degenerative syndromes, it is important
to develop efficient neuroprotective strategies that target molecular
mechanisms involved in synaptic collapse.
The human brain is a complex organ composed of (,200)
billion cells and even more complex interconnected cellular
interactions. Current experimental models used to study synaptic
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stability under pathological conditions range from whole animal
models that preserve the anatomical structures but greatly limit
experimentation at cell level, to dissociated cell culture systems
that allow detailed manipulation of cell phenotypes but lack the
highly ordered and instructive brain environment. In previous
work we and others demonstrated that microfluidic technologies
for cell culture are powerful tools allowing exquisite control of the
neuronal micro-environment and offering the possibility to
reconstruct fully functional neuronal pathways in vitro
[16,17,18,19], for review see [20,21], thus paving the way to
study neurodegenerative syndromes on chips. In the present study
we present a microfluidic platform allowing axotomy of recon-
structed neuronal pathways and show that chemical axotomy of
cortical fibers triggers a rapid presynaptic disconnection from
striatal dendrites. Our synaptic damage assay recapitulates the
molecular events previously mapped during in vivo experiments.
We perfused pharmacological compounds targeting specific
molecular pathways in the synaptic compartment, and used
automated image analysis quantification of presynaptic collapse.
We demonstrate that a rho Kinase inhibitor (Y27632), and
nicotinamide adenine dinucleotide (NAD+), exert strong synapto-
protective activities whereas zVAD-fmk and resveratrol fail to
protect synapses. We propose the use of this sophisticated ‘‘brain
on chip’’ as a versatile platform for fast evaluation of synapto-
protective drugs.
Material and Methods
Chip Design and Master Production
Microfluidic channels are made up of two elements: 55 mm high
macro-chambers for cell or fluid injection, separated by narrowing
arrays of 3 mm high micro-channels allowing directional axonal
outgrowth. The three compartmented chip (‘‘3C’’) was construct-
ed using the following design: two rectangular macro-channels
(length 4000 mm, width 500 mm, height 55 mm) separated by
arrays of asymmetrical micro-channels (length 500 mm, width 15
to 3 mm, height 3 mm, [17]) interrupted by a third macro-channel
inserted in the middle of the micro-channel ‘‘diode’’ array (see
Fig. 1a,b). This third macro-channel acts as an intermediate
compartment allowing control of the flow of solution over the mid-
portion of cortical axons [16].
To produce the template with elements of two different
thicknesses, we used two layers of photoresist (SU82005 and
SY355). A silica wafer was dehydrated by heating it to 150uC for
10 minutes and activated by plasma treatment (30s). A first layer of
SU82005 (Microchem) was spin-coated onto the wafer at
3800 rpm and then soft-baked at 65uC for 2 minutes and 95uC
for 4 minutes. The template was then exposed to UV light through
an optic mask (made of plastic or quartz if the required resolution
was less than 8 mm). After hard bake, the channels (3–4 mm high)
were developed in SU8 developer. The injection channels were
then produced by laminating the newly obtained wafer with a
55 mm-thick layer of dry film SY355 (Elga Europe) at 90uC. A
second mask was aligned over the SU8 channels and after
exposure to UV light, the channels were baked for 10 minutes at
120uC and developed in BMR developer, then rinsed with BMR
rinse, acetone and isopropanol.
The quality of the narrowing micro-channels was assessed by
white-light optical profiling (WLOP) in vertical scanning mode
(VSI), with an interference microscope WykoH NT1100 (Veeco
Instruments Inc., Plainview, NY, USA); this is a non-contact
optical profiling system, based on light interferences, that provides
high vertical resolution.
Microfluidic Chip Production
Polydimethylsiloxane (Sylgard 184, PDMS, Dow Corning,
Midland, MI, USA) was mixed with a curing agent (9:1 ratio)
and degassed under vacuum. The resulting preparation was
poured onto a polyester resin replicate and reticulated at 70uC for
2 hours. The elastomeric polymer print was detached and two
reservoirs were punched for each macro-channel. The resulting
piece was cleaned with isopropanol and dried. The polymer print
and a glass cover slip were treated for 200 seconds in an air plasma
generator (98% power, 0.6mBar, Diener Electronic, Ebhausen,
Germany) and bonded together. The chips were placed under UV
for 15 minutes and then coated with a solution of poly-D-lysine
(10 mg/mL, Sigma; St. Louis, MO, USA) overnight and washed
with PBS before cell seeding.
Primary Neuronal Cultures
Animal care was conducted in accordance with the standard
ethical guidelines of the CNRS ‘‘Formation a` l’Expe´rimentation
Animale’’ and approved by the ‘‘C2EA - 05 Comite´ d’e´thique en
expe´rimentation animale Charles Darwin’’. Timed pregnant mice
at E14 were purchased from Rene´ Janvier and cared for by the
well-established animal care facility at University Pierre et Marie
Curie (IFR83). Pregnant mice were decapitated and cortices and
striata were micro-dissected from E14 embryos of Swiss mice
(Janvier, Le Genest Saint Isle, France) and of a transgenic mice
strain expressing GFP (green fluorescent protein) under the control
of an actin promoter in all cell types [22]. All steps of dissection
were in cold phosphate buffer saline (PBS) supplemented with
0.1% glucose (Life Technologies, Inc., Gaithersburg, MD, USA).
Dissected structures were digested with trypsin-EDTA for striata
(Life Technologies, Inc., Gaithersburg, MD, USA) or papaı¨n for
cortices (20U/ML in DMEM, Sigma; St. Louis, MO, USA). After
tryspin or papaı¨n inactivation with fetal bovine serum (FBS, PAA
Piscataway, NJ, USA), structures were mechanically dissociated
with a pipette in presence of DNAse. After several rounds of
rinsing, cells were re-suspended in DMEM (Life Technologies,
Inc., Gaithersburg, MD, USA), to a final density of 45 million
cells/ml for cortices and 12 million cells/mL for striata. Cortical
cells were then seeded in the somatic compartment and striatal
cells in the distal compartment: 3 ml of the cell suspension was
introduced into the upper reservoir and cells flowed into the
chamber and adhered within 1–2 minutes. Cell culture medium
was then added equally to the four reservoirs (60 ml/reservoir).
Both neuronal cell types were grown in DMEM glutamax+strep-
tomycin/penicillin (Life Technologies, Inc., Gaithersburg, MD,
USA) +10% FBS+N2+ B27 (Life Technologies, Inc., Gaithers-
burg, MD, USA). Microfluidic chips were placed in plastic Petri
dishes containing H2O-EDTA to prevent evaporation and
incubated at 37uC in a humid 5% C02 atmosphere. The culture
medium was renewed every six days. Upon differentiation, 2 or
3 days after seeding, cortical axons entered the micro-channels
and reached the second chambers after 5 to 6 days. Cortical axons
continued growing thereafter.
Pharmacological Treatment
All chemicals were prepared as concentrated solution according
to the recommendations of the different manufacturers. Com-
pounds were aliquoted in Eppendorf tubes and used once to avoid
repeated freezing/thawing processes. Aliquots were stored at
280uC for no longer than two months. Care was taken to protect
photosensitive molecules from light by wrapping the test tubes in
aluminum foil. Drugs were extemporaneously diluted at their
respective final concentration in DMEM containing 10%
SVF+N2+ B27.
Microfluidic Synapto-Protective Assay
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For pharmacological pretreatments, medium was removed from
the striatal chambers and was replaced by DMEM containing the
pharmacological drugs. Except for NAD+, which was adminis-
trated overnight, pharmacological compounds were perfused one
hour before axotomy. The following concentrations were used for
control or axotomy conditions: resveratrol (20 mM, Sigma; St.
Louis, MO, USA), z-VAD (50 mM, Sigma; St. Louis, MO, USA),
Y27632 (10 mM, Sigma; St. Louis, MO, USA) or NAD+ (5 mM,
Sigma; St. Louis, MO, USA). After axotomy of the central
channel, fresh medium containing drugs was applied to wash
detergent.
Live Imaging
Live imaging of striatal dendritic spines was carried out using a
transgenic mouse expressing GFP under the control of an actin
promoter [22]. Non-transgenic cortical neurons were seeded in the
emitting chamber, while striatal neurons from the GFP-expressing
mouse were cultivated in the receiving chamber. Fluorescent live
imaging of striatal dendritic spines was carried out in control or
axotomized conditions for 6 hours using a 63X oil-objective.
Immunofluorescence
At various times, cultures were fixed in 4% paraformaldehyde
(PFA, Sigma; St. Louis, MO, USA) for 20 minutes at room
temperature. Cells were then washed twice with PBS for 5 minutes
and permeabilized for 45 minutes with 0.2% Triton X-100 and
1% BSA in PBS. Primary antibodies were then added and the
samples incubated at 4uC overnight in PBS. The samples were
rinsed twice for five minutes with PBS and further incubated with
the corresponding secondary antibodies for two hours at room
temperature. The chips were then rinsed once with PBS and once
with PBS+0.1% sodium-azide, and mounted in moviol mounting
medium. The following primary antibodies from Sigma (Sigma;
St. Louis, MO, USA) were used: a-tubulin-FITC (monoclonal 1/
700); Microtubule Associated Protein -2 (MAP-2, mouse mono-
clonal 1/500); Synaptophysin (mouse monoclonal 1/500); vesic-
ular glutamate transporter 1 (v-GLUT1, rabbit polyclonal 1/500,
gift E. Herzog, CNRS, UMR 7224). Species-specific secondary
antibodies coupled to Alexa 350, 488, or 555 were used (1/500,
Life Technologies, Inc., Gaithersburg, MD, USA) to visualize
bound primary antibodies.
Neuronal Network Axotomy
After full maturation of the neuronal network (14 days after
seeding), cell culture medium was removed from the two reservoirs
connecting the central chamber, and solution of plain DMEM
(sham) or 0.1% Triton in DMEM was flowed from the upper
reservoir for 30 seconds. Careful attention was paid to the fluidic
isolation of the central channel: the two outer cell culture
chambers were pressurized with 50 ml of cell culture medium
while 20 ml of sham or detergent-containing medium were
introduced into the upper reservoir of the central channel. This
created a flux of detergent into the central chamber containing the
cortical axons. The central chamber was then washed three times
Figure 1. Reconstruction of oriented neuronal networks in 3C-microfluidic chip. a: Microfluidic neuronal culture devices are made up of
two separate cell culture chambers (blue) interconnected by a series of asymmetrical micro-channels interrupted by a central narrow (50 mm-wide)
channel that gives access to the central part of the axons. Each chamber is perfused individually by two reservoirs (indicated by R). b: Phase contrast
image of a reconstructed oriented neuronal network in 3C-chip. Cortical neurons are seeded in the left chamber and connect striatal neurons seeded
in the right chamber (red stars). The size of asymmetrical micro-channels allows the outgrowth of axons but prevents the entry of cell bodies; micro-
channels allow the passage of axons only in a left-to-right direction (axonal diodes) scale bar = 50 mm. c–c’: Immunofluorescent images of the
receiving (right) chamber. Cortical axons exit micro-channels (green: a-tubulin) and cluster presynaptic markers (red: v-GLUT1) on striatal dendrites
(blue: MAP-2). c’: Enlargement of the clustering of cortical presynaptic labeling on striatal dendrites, suggesting cortico-striatal synapse
establishment. scale bar = 20 mm.
doi:10.1371/journal.pone.0071103.g001
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with DMEM and the central reservoirs were then filled with
medium. Axotomized cells were then kept at 37uC under 5% CO2
for various periods before fixation.
Image Acquisition
Images were acquired with an Axio-observer Z1 (Zeiss,
Germany) fitted with a cooled CCD camera (CoolsnapHQ2,
Ropert Scientific). The microscope was controlled with Meta-
morph software and images were analyzed using ImageJ and
SynD software [23].
Quantification of Synaptic Disconnection
Synaptic disconnection was assessed by counting v-GLUT1
clusters affixed to MAP-2 positive striatal dendrites. All images
were obtained using the same acquisition parameters. The images
were similarly processed with ImageJ software before being used
for quantification: the brightness/contrast of all control images
was optimized manually to eliminate the background and to
maximize the signal. The means of the minimum and maximum
intensities were then calculated in the control condition and these
settings were applied to all images. The images of the three
stainings v-GLUT1/a-Tubulin/MAP-2 were merged and the
resulting image was used to define the zone where striatal
dendrites were sufficiently innervated by cortical fibers. A v-
GLUT1/MAP-2 merge was then used for quantification using
SynD software (Fig. S1). The merged v-GLUT1/MAP-2 images
(Fig. S1A) were analyzed using SynD [23]. Here the somata were
detected by thresholding the MAP-2 channel, and smaller
structures such as neurites were removed by morphological
erosion followed by dilation (Fig. S1B). Neurites were detected
using steerable filters applied to the MAP-2 channel (Fig. S1C).
Finally, synapses were detected by thresholding the v-GLUT1
channel to get a synapse mask (Fig. S1D) and then putative
individual synapse centers were detected by deconvolving the
original v-GLUT1 channel and locating peaks (Fig. S1E). Only
synapses detected on or near the neurites were included for
analysis. The resulting synapse counts were then exported to Excel
for further analysis. The settings used were: Soma erode = 25;
Morphology threshold = 35; Max cost = 0.9; Steerable filter size (in
mm) = 1.6; Synapse intensity threshold in standard deviations
above noise = 0.3; Neurite padding (zone in mm outside neurite
mask where synapses are counted) = 8; Minimal size = 0.3 mm.
Reported values are means for at least three independent
experiments, each performed in triplicate.
Statistical Analysis
For synapse quantification, differences were assessed by
ANOVA, followed, when appropriate, by a post-hoc Bonferoni
test. For all analyses: *p-value,0.05; **p-value,0.01; ***p–
value,0.001.
Results
Setting up a Microfluidic Cell System to Model Axonal
Injury in Oriented Neuronal Networks
To assess the impact of axonal injury on distant presynaptic
dynamics we designed a microfluidic platform allowing the
manipulation of reconstructed neuronal networks encompassing
three separate sub-compartments (Fig. 1). This was achieved by
combining two approaches previously developed in our laborato-
ries. The first system was designed to allow easy axotomy of
neuronal axons in a three-compartment chip presenting a somato-
dendritic compartment, a narrow central channel giving access to
the central part of the axons, and a distal receiving chamber
containing axons [16].The second system comprised asymmetrical
micro-channels to polarize axonal growth and reconstruct oriented
neuronal networks in vitro in a two-compartment chip [17].
The new device is composed of a three-compartment chip in
which the diode array is interrupted by a 50 mm-wide central
channel (Fig. 1a and b).The system is made up of two distinct cell
culture chambers (for each neuron type), each connected to two
reservoirs (indicated by an R in Fig. 1a) and separated by an array
of 500 mm-long narrowing micro-channels allowing unidirectional
axonal growth (from the proximal chamber to the distal one) and
interrupted by a third central channel giving access to the central
part of the axons (orange channel in Fig. 1a). Using this multi-
compartment device, we next reconstructed an oriented cortico-
striatal neuronal network in which the somatic, axonal and
synaptic compartments of cortical neurons are specifically
accessible through fluidic perfusion. To that purpose, mouse
primary cortical neurons were seeded in the left chamber (on the
wider side of the narrowing micro-channels), and striatal neurons
from the same mouse were seeded in the receiving chamber.
Fig. 1b shows phase contrast micrographs of cortical neurons
projecting towards striatal neurons. Neurons seeded in the
chamber with large micro-channel openings emit axons that
invade the micro-channels and grow within these tubes. When
exiting the first array of micro-channels, about 80% of the cortical
fibers crossed the central chamber, reached the second array of
narrowing micro-channels and continued to grow to connect
striatal neurons seeded in the receiving cell culture chamber
(Fig. 1b). As described previously [17], due to the small size of the
micro-channel tips, axons from the receiving striatal chamber
bumped into the sidewall of the chamber and did not shoot
towards the cortical chamber. Fifteen days after cell seeding, the
neuronal network was fully established and cortical fibers were
connected to fully differentiated striatal neurons, as evidenced by
the docking of VGLUT1 positive presynaptic cortical terminals to
MAP-2 positive striatal dendritic arborization (Fig. 1c’) and the
presence of GFP positive dendritic spines on striatal dendritic
shafts. Connected striatal neurons showed slow spontaneous
calcium oscillation imposed by cortical spontaneous rhythms (data
not shown and [17]). Overall, introducing a central chamber
dedicated to the manipulation of the mid portion of cortical fibers
did not modify neuronal differentiation in reconstructed networks.
Kinetics of Structural Alterations after Cortical Fiber
Axotomy
Synaptic and axonal degeneration are two of the earliest
structural alterations occurring in various acute and chronic
neuronal pathologies, and often precede the destruction of the cell
body. Severing of peripheral or central nerves is widely used as an
experimental model of brain and axonal trauma in order to
decipher specific molecular pathways involved in axonal degen-
eration. However, the molecular mechanisms and kinetics
involved in presynaptic breakdown of nerve terminals remain
elusive. In order to assess the impact of axonal trauma on synaptic
terminals we axotomized the reconstructed cortico-striatal neuro-
nal network. Axotomy was carried out by perfusing cell culture
medium containing 0.1% Triton for 30 seconds in the central
compartment containing cortical axons (Fig. 2a–f). As shown in
Fig. 2e we monitored minute severing of cortical axons within the
central channels without damaging the proximal parts of the fibers
within the micro-channels. We next performed a kinetic analysis of
neuronal network component degeneration. The cortical somato-
dendritic compartment showed no signs of either tubulin
architectural alterations or dendritic alteration following axotomy
(MAP-2 and a-tubulin staining, Fig. 2a,d). The portion of axon still
Microfluidic Synapto-Protective Assay
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connected to the cortical soma was able to re-grow after axotomy
(data not shown), thus indicating that axotomy of cortical fibers
does not trigger a retrograde death signaling process. Compared to
sham perfused fibers (Fig. 2g), severed cortical axons in the striatal
chamber (Fig. 2h) displayed no signs of axonal tubulin fragmen-
tation even two hours after axotomy. Axonal degeneration started
four hours after lesion (i) with sparse tubulin beading (axonal
blebs); six hours after axotomy all axons were fragmented (j).
Meanwhile, the global architecture of the striatal dendritic tree
(revealed by MAP-2 labeling) remained globally unaffected during
the first six hours.
The number of cortical v-GLUT1 clusters on striatal dendrites
was counted by widefield epifluorescence microscopy at various
times after axotomy. Under control conditions (Fig. 3a,c), there
were approximately 40 v-GLUT1presynaptic terminals per
100 mm of striatal dendrite. Two hours after axotomy, the number
of presynaptic cortical clusters on striatal fibers was 60% lower
(Fig. 3d) than in control cultures (Fig. 3c), whereas cortical axons
showed no signs of blebbing or disorganization of their microtu-
bular network. Four hours after axotomy (when the first sign of
axonal alteration appeared), presynaptic density was 75% lower in
axotomized conditions (Fig. 3e) compared to sham experiments
(Fig. 3a,c). Finally, six hours after axotomy, when the cortical
axons were almost all fragmented (Fig. 2j), presynaptic v-GLUT1
staining had completely disappeared (Fig. 3f), indicating complete
destruction of cortico-striatal synapses. We concluded that cortical
axotomy triggers a progressive cortico-striatal synaptic disconnec-
tion, which precedes the fragmentation of cortical axons.
As shown in Fig. 2g–j, the global architecture of striatal neurons
did not seem to be altered during the axotomy time course.
However, we wondered whether presynaptic cortical degeneration
would induce a milder postsynaptic alteration. Non-transgenic
cortical neurons were seeded in the emitting chamber, while
striatal neurons from a transgenic mouse expressing GFP (green
fluorescent protein) under the control of an actin promoter were
grown in the receiving chamber. Fluorescent live imaging of
striatal dendritic spines was carried out in control or axotomized
conditions for six hours (Fig. 3g–n). In control conditions, striatal
spines were stable (Fig. 3g–j). Following cortical fiber axotomy the
striatal spines remained stable even when cortical pre-synapses
previously connecting those spines had almost all degenerated
(Fig. 3k–n). These observations suggest that presynaptic disorga-
nization represents one of the primary events induced by axonal
damage, which in turn induces the anterograde propagation of a
fast degenerative signal within the axons.
The loss of presynaptic clusters was also associated with the
apparent dispersal of the residual v-GLUT1 vesicles (not shown).
There are several possible explanations for this observation. First,
v-GLUT1-positive vesicles may disperse along axon fibers due to
local modification of the mechanical tension of axonal fibers
triggered by axotomy. Second, dispersion of v-GLUT1 and
presynaptic proteins may be associated with the collapse of the
whole structure of the spine. It would be of interest to monitor the
dynamics of v-GLUT1 movement, using v-GLUT1-GFP chimeric
protein, to address this issue.
Live imaging of striatal dendritic spines revealed that striatal
spines did not degenerate within the same time-window as pre-
synapses (compare Fig. 3g–n with Fig. 3a–f). Even four hours after
axotomy, when almost all the synapses had degenerated and axons
started to fragment, striatal postsynaptic architecture remained
intact (Fig. 3m). This suggests that structural postsynaptic integrity
can be preserved for at least four hours after the loss of presynaptic
structures.
Pharmacological Evaluation of Synapto-protective Drugs
in 3C-microfluidic Chip
Using the above data it was possible to identify a time-window
within which pre-synapses had almost all degenerated after
cortical axotomy while axons or postsynaptic elements remained
intact. This time-window can be used to screen for drugs expected
to have the capacity to slow down or prevent synaptic loss.
With the help of our microfluidic-based synaptic stability/
degeneration assay, we first quantified synaptic degeneration using
SynD software (see [23] and Fig. S1), which allows automatic
segmentation of striatal dendritic trees and co-localization of v-
GLUT1 positive synapses docked to the dendrites. Automatic
counting was used to evaluate the number of v-GLUT1 clusters on
Figure 2. Kinetics of axonal degeneration following cortical axotomy in a network. a,d: Cortical, b,e: central and c,f: striatal, chambers of
normal (a–c) or axotomized (d–f) reconstructed cortico-striatal networks (div14). Neurons were stained for MAP-2 (blue), a-tubulin (green) and v-
GLUT1 (red). a–c: Cortical neurons send axons efficiently through the micro-channels and the central chamber to reach, and connect with, striatal
neurons. d–f: Two hours after axotomy, no axons are present in the central chamber but axons inside the micro-channels and in the striatal chamber
remain intact. scale bar = 75 mm g–j: Kinetics of degeneration of the distal part of the cortical axons following axotomy of cortical fibers in the
receiving chamber. No axonal fragmentation (assessed by a-tubulin, green) is observed either in non-axotomized condition (g), or two hours after
axotomy (h). The first tubulin beads (blebs) on cortical axons appear four hours after axotomy (i), and after six hours, all cortical axons disconnected
from their soma are fragmented whereas striatal morphology remains intact (MAP-2, bleu) (j). scale bar = 20 mm.
doi:10.1371/journal.pone.0071103.g002
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striatal dendrites in control conditions (Fig. 4a–e) or three hours
after axotomy (Fig. 4f–j), when cortical pre-synapses have normally
degenerated (but not cortical axons or striatal spines).
We then selected several pharmacological compounds known to
impede synaptic and/or axonal degeneration in vivo. Although the
precise molecular events triggered in synaptic destruction upon
neurodegenerative stimuli are still unknown, previous experiments
conducted after in vivo axotomy of peripheral nerves have shown
that presynaptic collapse at the neuromuscular junction is
triggered by a caspase-independent, NAD+-dependent signaling
pathway. However, whereas there is no doubt about the
involvement of caspases in cell body destruction, their role in
axonal and synaptic degeneration is still an open question.
We therefore decided to evaluate the synapto-protective
potential of both NAD+ and z-VAD-fmk, a broad-spectrum
caspase inhibitor. The cultures were pretreated for one hour with
z-VAD-fmk (50 mM) (Fig. 4c,h) or for 24 hours with NAD+
(5 mM) (Fig. 4e,j). Cultures pretreated with NAD+ and subjected
to axotomy retained 65% of the initial number of synapses
whereas non-pretreated cultures retained 25% (Fig. 4k). In
contrast, no significant synapto-protection was found in cultures
pretreated with z-VAD-fmk (Fig. 4k). We also investigated the
protective potential of resveratrol on synapses. As resveratrol, an
activator of Sirtuins (a group of NAD+ dependent histone
deacetylases) has been shown to have a similar protective effect
on axons to NAD+ (Araki et al, 2004), we decided to evaluate its
protective potential on synapses. However, in our experimental
conditions, pretreatment with 20 mM resveratrol (1 h and 24 h)
did not show any protective potential on synapses (Fig. 4b,g,k).
Finally, actin being a key component of pre and post-synapses
which controls different aspects of synaptic physiology, we
included a Rho Kinase inhibitor (Y27632) [24]. Interestingly, a
strong synapto-protection was obtained with the Rho-kinase
inhibitor (10 mM, 1 h pretreatment) with 75% of synapses
preserved, indicating that ROCK may play an important role in
presynaptic stability under stress. Our experimental setup thus
successfully demonstrated that cortical axotomy induces synaptic
disconnections preceding axonal degeneration and that NAD+ and
Rho-kinase inhibitor have a specific protective effect against this
cortico-striatal disconnection.
Discussion
This tri-Compartiment (3C)-microfluidic system for neural
network reconstruction and pathological process modeling is a
good example of the interest of microfluidic for neurosciences.
What neuroscientists need are sophisticated but easy to handle
biological models to help solve complex neuro-scientific issues
[20,21]. Due to the inherent complexity of the organization of the
brain, many questions regarding developmental issues, neuronal
activities in complex networks and the mechanisms of neurode-
generation in either acute or neurodegenerative diseases remain
unanswered. The lack of relevant but simplified models of
neuronal networks has slowed down the development of efficient
drug therapies which protect synapses and prevent network
dysfunctions. Here we show that this new structured network
integrating different neuron types that reproduce essential
properties of neuronal communication is easy to handle and
Figure 3. Early cortico-striatal synaptic disconnection after cortical fiber axotomy. a–f: Cortical presynaptic structures (v-GLUT1, red)
affixed to striatal dendrites (MAP-2, blue) in control conditions (a), three hours after axotomy (b)scale bar: 20 mm. Note the disappearance of v-GLUT1
labeling suggesting cortical presynaptic degeneration. c–f: Representative high magnification images in control conditions (c) and two hours (d), four
hours (e) and six hours (f) after axotomy. Note the fast cortico-striatal disconnection as soon as two hours after axotomy. scale bar: 5 mm. g–n: Live
imaging of GFP-expressing striatal neurons at time 0h (g,k), 2h (h,l), 4h (i,m) and 6h (j,n) in control (g–j) or axotomy (k–n) conditions. Note the
stability of striatal dendritic spines (arrow) in both conditions. scale bar: 15 mm.
doi:10.1371/journal.pone.0071103.g003
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greatly facilitates the evaluation of synapto-protective drug
potency.
Apoptosis is generally accepted to be a key event triggering
neuron death in late-onset neurodegenerative diseases, yet their
role in axonal and synaptic degeneration is unclear. Although
caspases 3 and 9, which are key effectors of the apoptotic pathway,
can be activated locally in synaptic terminals and neurites,
resulting in local functional and morphological modifications
[25,26], they do not seem to play an active role in axotomy-
induced axonal degeneration [27,28]; see review [29,30,31].
Although it has been postulated that modest synaptic caspase
activation might be involved in local non-apoptotic mechanisms
such as long term depression [25,26], our findings showing that
caspase inhibitors failed to protect synapses after acute axonal
injury further suggest that caspase activation is not a crucial
mechanism in the synaptic degeneration process. Our findings are
in line with the data showing that caspases are not involved in
Wallerian degeneration processes, where it is rather NAD+
signaling which is involved. Indeed, the WldS gene was shown
to confer a strong axo and synapto-protective effect at the
neuromuscular junction through an age-dependent process. This
gene mediates its effects partly through its nicotinamide mon-
ucleotide adenylTransferase-1 NMNAT1 moiety, an NAD+
producing enzyme [32]. Interestingly, in the CNS, the WldS gene
delays nerve terminal degeneration in the striatum following
ablation of the ipsilateral cerebral cortex [33]. Here we show that
exogenous NAD+ strongly protects synapses after axonal trauma
and confirm the importance of NAD+ signaling pathways in
synaptic maintenance. However, both the targets of NAD+ and its
site of action remain elusive. NAD+ is a molecule involved in
many reactions and cellular functions including energetic metab-
olism, mitochondrial functions, and antioxidant defenses. It has
long been postulated that NAD+ exerts axo-protective effects
through nuclear signaling [34] but recent experiments have
demonstrated that extra-nuclear NAD+ producing enzymes have
the same effect [35]. Thus, although the mechanisms of NAD+
synapto-protective effects remain enigmatic, our data suggest that
synaptic application of NAD+ may act locally to protect synapses
after acute axonal injury. Finally, the results we obtained with
caspase inhibitors and exogenous NAD+ are in line with data
gathered from in vivo models, and therefore ensure the reliability of
our evaluation assay. This encouraged us to assess the synapto-
protective properties of two compounds targeting pathways
potentially involved in synaptic collapse.
Among NAD+ potential targets, sirtuins represent attractive
candidates. They are NAD+ dependent class III histone
deacetylase involved in controlling longevity [36]. Sirtuin 1
(SIRT1) has previously been shown to mediate the axo-protective
effect of WldS protein on axotomy [34]. Resveratrol that activates
several sirtuins through indirect signaling pathways involving both
AMPK activation and NAD+ production [37,38], has been shown
to have a similar axo-protective effect, once applied to entire
neurons [34]. However, these results were not confirmed in
another degenerative paradigm [39], and its effect on synapse is
not known. It was therefore tempting to assess whether or not local
(synaptic and axonal) application of resveratrol could delay
synaptic destruction in our paradigm. The failure of synaptic
application of resveratrol to directly protect synapses contrasts
with the NAD+ protective effect. This may be due to the fact that
resveratrol targets (either direct or indirect) are not expressed or
enriched enough in presynaptic terminals to trigger a strong
protective effect. This does not, however, rule out the possibility
that resveratrol may exert a synapto-protective effect through long
distance signaling such as nuclear SIRT1 activation, for example.
Finally, we wanted to see whether molecules which interfere
with actin dynamic could slow down presynaptic collapse triggered
by cortical fiber axotomy. In previous work we and others have
shown that axotomy of cortical axons triggers a rapid collapse of
actin filipodia in unconnected axons [16,40,41]. Pre and post
synaptic elements are greatly enriched in actin networks and are
virtually devoid of tubulin cytoskeleton. Actin dynamic controls
most of the synaptic physiology. Among the effectors that control
actin polymerization/depolymerization in neurons, Rho GTPase
and Rho Kinase (ROCK), a group of serine/threonine kinases, are
important players [42]. While the role of Rho GTPase in
controlling dendritic and synaptic dynamic is becoming clearer,
little is known about the role of Rho Kinase in synapses. ROCK
signaling was recently involved in mediating growth cone collapse
triggered by chemo-repulsive cues during brain development [43]
and in controlling the readily releasable pool of synaptic vesicles
[44]. Our results demonstrating that Y27632 is a potent inhibitor
of presynaptic collapse show that ROCK are early effectors
Figure 4. Pharmacological screen of synapto-protective drugs
in 3C-microfluidic chip. a–j: Representative high magnification
images of cortical presynaptic structures (v-GLUT1, red) affixed to
striatal dendrites (MAP-2, blue) in non-axotomized (a–e) and 3 hours
post-axotomy (f–j) conditions, without treatment (a,f), or with
resveratrol (20 mM b,g), 50 mM z-VAD (c,h), 10 mM Y27632 (d,i) or
5 mM NAD+ (e,j) pre-treatment. scale bar: 5 mm. k: Quantification of
cortical presynaptic structures affixed to MAP-2-positive striatal
dendrites after cortical axotomy. The graph represents the relative
number of synapses remaining compared to non-axotomized condi-
tion. Y27632 and NAD+ delay cortical synaptic loss whereas no
significant protection is observed with resveratrol or z-VAD pre-
treatment.(ANOVA 2, *p-value,0.05, **p-value,0.01). Synaptic degen-
eration was quantified using SynD software (see Figure S1) which allows
automatic segmentation of striatal dendritic trees and co-localization of
VGLUT1 positive synapses docked to the dendrites [23].
doi:10.1371/journal.pone.0071103.g004
Microfluidic Synapto-Protective Assay
PLOS ONE | www.plosone.org 7 August 2013 | Volume 8 | Issue 8 | e71103
mediating destructive events involved in synaptic dismantlement.
ROCK 2 was recently isolated in a proteomic and genomic screen
aimed at isolating molecular effectors involved in synaptic
degeneration [45]. It is thus tempting to propose that inhibitors
of ROCK could represent interesting pharmacological compounds
for further translational development.
Conclusions
Microfluidic devices have facilitated investigation in biology in
new ways, thanks to the structuring of the in vitro model, micro-
environment control, and design flexibility. This work, which
follows the trend of ‘‘organ on chip’’ research, shows that
microfluidic platforms for nerve pathway reconstruction are useful
tools for the study of both developmental and degenerative
processes at several levels, ranging from sub-cellular compartments
to integrated neuronal networks. Here we show that the use of this
new sophisticated but still simple to handle in vitro reconstructed
neuronal network not only allows basic biological questions to be
addressed but also represents a valuable and relevant tool for fast
screening of synapto-protective drugs. Using this strategy, it has
been possible to reveal for the first time that Rho kinase may
represent interesting targets to delay synaptic collapse after injury.
If this could speed up and improve the reliability of the validation
and characterization stages when developing therapeutic drugs,
this would already be a great step forward.
Supporting Information
Figure S1 Automated quantification of synapses with
SynD software. Synaptic disconnection was assessed by
counting v-GLUT1 clusters affixed to MAP-2 positive striatal
dendrites. Images were all obtained with the same acquisition
parameters and were similarly processed with ImageJ software
before being used for quantification. (a) v-GLUT1/MAP-2 merge
used for quantification using SynD software.(b) Automatic soma
detected using thresholding followed by morphological opening
and closing. (c) Dendrites detected using steerable filters. A cost
function evaluates each pixel around the current neurite mask, and
those with a cost lower than a specified threshold are added to the
mask. The cost function takes into account how neurite-like the
neighborhood around the candidate pixel is (i.e. ideally a bright
line segment surrounded by dark regions on either side), and if the
candidate pixel is in the direction of the already detected parts of
the neurite. (d) The detected neurite mask overlaid on the v-
GLUT1 channel, only the parts located either within the neurite
mask or a small neighborhood around it are used for synapse
detection. (e) Synapse regions are detected by thresholding the v-
GLUT1 channel; putative centers are located by deconvoluting
the image.
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